Armstrong Coal Company, Inc. v. Nathan Attebury

Kentucky Supreme Court·Decided May 22, 2017·No. 2016 SC 000368·Unknown

Opinion

llleoRTANT NoTlcE NoT To BE PuBLlsHED 0PlNloN

THls 0PlNloN ls DEslGNATED "NoT To BE PuBLlsHED.” PuRsUANT To‘_THE RuLEs oF clvlL PRocEDuRE PRolvluLGATED BY THE suPREME couRT, cR 76.28(4)(€), THls 0PlNloN ls NoT To BE PuBLlsHED AND sHALL NoT BE clTED oR usED As BlNDlNG PREcEDENT lN ANY oTHER cAsE lN ANv-couRT oF THls sTATE; HOWEVER, uNPuBLlsHED KENTucKY APPELLATE DEclsloNs,k RENDERED AFTER JANuARY 1, 2003, MAY BE clTED FoR coNleERATloN BY THE couRT lF THERE ls No PuBLlsHED 0PlNloN THAT wouLD ADEQUATELY ADDREss THE lssuE , BEFoRE THE couRT. oPlNloNs clTED FoR coNleERATloN BY THE couRT sHALL BE sET ouT As AN uNPuBLlsHED DEclsloN lN THE FlLED DoculleNT AND A coPY oF THE ENTlRE DEclsloN sHALL BE TENDERED ALoNG wlTH THE DocuMENT To THE couRT AND ALL PARTlEs To THE AchoN,

RENDERED:- APRIL 27, 2017 -Lis ED'

Supreme Tnuc‘f of IG(EN P

20 16-SC¢OOO368-WC ` ` [:D)AT |E§/lglrl l<¢i» Qumm .z>c, ARMSTRONG coAL coMPANY, INC. l A'PPELLANT ON APPEAL FROM COURT OF APPEALS CASE NO. 20 15-CA-OO 1545-WC V. WORKERS’ COMPENSATION BOARD No. 14-__WC-90179

NATHAN ATTEBURY; - . APPELLEES

HON. CHRIS DAVIS, ADMINISTRATIVE LAW JUDGE; AND 'WORKERS’ COMPENSATION BOARD MEMORANDUM OPINION OF THE COURT AFF-IRMING

An Administrative Law Judge (ALJ) found that Nathan Attebury developed toxic encephalopathy and is permanently totally disabled as a result of exposure to toluene, a chemical in` Krylon paint, while working for Armstrong Qoal Company, Inc. The Workers’ Conipensation Board (the Board] afflrmed, as did a divided panel of the Court of Appeals. On appeal to this Court, Armstrong arguesl as it did below`, that the ALJ’s findings were not supported by evidence of substance For the following reasons, we disagree and affirm.

l. BACKGROUND.

Attebury was born on June 8, 1981. He has a high school education and

his mine-foreman certification, and he has worked as-a construction laborer, in

a clothing factory, and 'as an underground coalminer.` Approximately six

months after he started working for Armstrong, Attebuty began to experience headaches,_ dizziness, short-term memory loss, and‘confusion. His symptoms progressiver worsened, and he stopped working in January 2014. Attebury testified that he had previously suffered from seasonal affective disorder, for which he took an anti-depressant,land from panic attacks, anxiety, and headaches. Attebury also testified that he had been prescribed Suboxone in' order to wean himself from Lortab that he took following a neck inj`uIy. d

Attebury first sought treatment for his symptoms with Dr. Jayna Jones in‘JanuaIy 2014. Dr. Jones noted that Attebury complained of dizziness, headaches,\ memory loss, social anxiety, occasional '“blackout spells,” and confusion. Attebury attributed his symptoms to the paint he was using at work and stated that his symptoms improved when he was off work for any length of time. Dr. Jones referred Attebury to Dr. Michael Mayron, a l neurologist

Dr. Mayron, who first treated Attebury on February 17, 20 14, noted that Attebury had neuropathy in his left arm and leg, tremors in both hands, and severe memory impairment Following his examination and a review of medical literature, Dr. Mayron made a diagnosis of toxic encephalopathy, which he attributed to Attebury’s exposure to the chemical toluene, a component of the Krylon spray paint Attebury used at work. Based on Attebury’s memory loss and inability to perform multi-step tasks, Dr. Mayron assigned him a 49%

impairment rating. In his report and during his deposition, Dr. Mayron

referred to an article from the Annals of Néurology from June 1988 to support his conclusions that Attebury’s condition was related to exposure to toluene. During his deposi-tion,' Dr. Mayron stated that he had reviewed other articles, which he did not have readily available. However, he supplied copies of those articles to the court reporter after his deposition. `We discuss the articles Dr. Mayron relied on in more detail below.

Armstrong.filed the report of Dr. Dennis O’Keefe,.a neurologist who performed an independent medical evaluation of Attebury at Armstrong’s request In his report, Dr. O’Keefe stated that Attebury complained of depression, anxiety, headaches, and memory loss that became severein December 2013. Dr. O’Keefe’s examination revealed deficits _in immediate recall, attention, and calculation; ‘an “essentially normal” ability to speak and . answer questions; and lightheadedness after two minutes of hyperventilation. Dr. O’Keefe stated that two chemicals in Krylon paint could cause neurological problems: xylene, which causes dizziness, lightheadedness, and other symptoms; and N-hexane, which causes neuropathyin the extremities. He noted that Attebury had no symptoms of extremity neuropathy and that symptoms associated with xylene exposure generally resolve once exposure to the chemical stops. .-Based on the preceding, Dr. O’Keefe concluded that Attebury’s symptoms were not related to- exposure to chemicals in K.rylon but to lAttebury’s depression, which Dr. O’Keefe attributed to “claustrophobia

associated with” working in an underground coalmine.

Before the ALJ, Armstrong argued that Dr. Mayron’s opinion regarding causation was not probative because he: had no history of Attebury’s prior complaints of headaches; relied on literature-that pertained “to a different type of toluene exposure testing in a different type of injury;” and did not know how much Krylon Attebury used, how he used it, how often he used it, or whether Attebury had any other exposure to toluene. Armstrong also argued that the amount of toluene Attebury was exposed to was below OSHA"s permissible limits. 7

The-ALJ disagreed with Armstrong and found as follows§

On the issue of causation both Dr. Mayron and Dr. O’Keefe have provided an opinion. Both have independently researched the effects of the Krylon paint used by the Plaintiff. Both have- concluded that the paint can cause neurological effects. From that point their opinions diverge. n

Dr. O’Keefe believes the paint can cause two different types of neurological condition[s]. The first, primarily effecting the limbs, the Plaintiff does not have. The second, according to Dr. O’Keefe, is not permanent and its effects should resolve entirely when exposure to th_e paint stops. Dr. O’Keefe affirmatively states the Plaintiff does not have toxic encephalopathy, regardless of causation. Dr._, O’Keefe affirmatively states the Plaintiff has no work-related condition.

Dr. Mayron states that one of the potential side effects _Of the K_rylon paint is toxic encephalopathy This is the diagnosis he makes for the Plaintiff. 'He states the toxic encephalopathy is ` work-related. Dr. Mayron testified in his deposition that he extensively reviewed the Krylon paint, particularly the toluene. It can cause_the toxic encephalopathy and it can cause all of the Plaintiff’s neurologic symptoms. The_ damage is permanent In short, while I respect both physicians who provided an opinion regarding causation I am more inclined to find the opinion of Dr. Mayron persuasive. He is a treating physician with no known or demonstrated bias. His is a very specific field and area of expertise to which he devotes his practice, i.e. neurological conditions. He has demonstrated the scholarly texts he relies upon. There is no

other known source of causation for the Plaintiff's symptoms, as I agree that the ADHD, anxiety or depression is not causing .them.

I am not persuaded by the Defendant’s argument that Dr. Mayron

had insufficient knowledge regarding the amount of toluene

exposure. The Plaintiff testified to me and related to Dr. _Mayron

his exposure levels. That it was not measured in parts per milliliter

Free access — add to your briefcase to read the full text and ask questions with AI

Armstrong Coal Company, Inc. v. Nathan Attebury, (Ky. 2017).

Armstrong Coal Company, Inc. v. Nathan Attebury (Armstrong Coal Company, Inc. v. Nathan Attebury) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Whittaker v. Rowland
998 S.W.2d 479 (Kentucky Supreme Court, 1999)
Western Baptist Hospital v. Kelly
827 S.W.2d 685 (Kentucky Supreme Court, 1992)
Wolf Creek Collieries v. Crum
673 S.W.2d 735 (Court of Appeals of Kentucky, 1984)
Shalaby v. Bernzomatic
281 F.R.D. 565 (S.D. California, 2012)